Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower
Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower

Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower

DSIJ Intelligence Article rating: 2.4

Dr Lal PathLabs announced its financial results for quarter ending September 2020 today. Non-COVID business was back to 98 per cent of last year levels in Q2FY21. Revenue increased in Q2FY21 by 18.2 per cent to Rs 431.9 crore from Rs 365 crore last year during the same quarter.

TMCA selects Cigniti Technologies as strategic quality engineering partner
TMCA selects Cigniti Technologies as strategic quality engineering partner

TMCA selects Cigniti Technologies as strategic quality engineering partner

DSIJ Intelligence Article rating: 4.2

Cigniti Technologies, a global leader in independent quality engineering & software testing services, announced on Monday that it has now become a strategic quality engineering panel vendor for Toyota Motor Corporation Australia (TMCA). It would help accelerate its quality & digital transformation journey over the next 3 years.

Motherson Sumi Systems gives trendline breakout
Motherson Sumi Systems gives trendline breakout

Motherson Sumi Systems gives trendline breakout

Vinayak Gangule Article rating: 3.4

The stock of Motherson Sumi Systems Limited has given a downward sloping trendline breakout, formed by connecting swing highs since August 2020. This breakout is confirmed by the above 50-day average volume.

Akzo Nobel trades in green as demand improves due to festive season
Akzo Nobel trades in green as demand improves due to festive season

Akzo Nobel trades in green as demand improves due to festive season

Nidhi Jani Article rating: 4.3

 The demand in the metro cities remained muted during the quarter and has improved due to the festive season and pent-up demand. The revival in the automotive sector benefitted the business while infrastructure, oil & gas and power segments continued to see demand challenge.

Alembic Pharma receives one more ANDA
Alembic Pharma receives one more ANDA

Alembic Pharma receives one more ANDA

DSIJ Intelligence Article rating: 3.5

Alembic Pharmaceuticals Limited announced during the first half of the trading session (at around 10 am to be specific) that it has received tentative approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Palbociclib capsules, 75 mg, 100 mg, and 125 mg. 

Blue Star share rises on winning order worth Rs 128 crore
Blue Star share rises on winning order worth Rs 128 crore

Blue Star share rises on winning order worth Rs 128 crore

DSIJ Intelligence Article rating: 3.2

Blue Star Limited is experiencing a gradual increase in the inflow of orders for bundled services. Presently, this order is one of the largest and fast-track projects, which is being executed by Blue Star in the factories’ segment.

Balkrishna Industries: Volume jumps 61 per cent QoQ in Q2FY21
Balkrishna Industries: Volume jumps 61 per cent QoQ in Q2FY21

Balkrishna Industries: Volume jumps 61 per cent QoQ in Q2FY21

Nidhi Jani Article rating: 4.7

On the volumes’ front, the company reported the highest-ever quarterly sales volume in Q2FY21. Besides, it registered a significant jump of 60.71 per cent QoQ to 61,224 MT in Q2FY21 vs 38,096 in Q1FY21.

RSS
First27852786278727882790279227932794Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR